Fingerprint
Dive into the research topics of 'Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation
Shanna A. Arnold, Lee B. Rivera, Juliet G. Carbon, Jason E. Toombs, Chi Lun Chang, Amy D. Bradshaw, Rolf A. Brekken
Research output: Contribution to journal › Article › peer-review
67
Scopus
citations